Susquehanna International Group, LLP Bei Gene, Ltd. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $8.35 Million - $13 Million	58,000 Added 124.2%	104,700 $23.5 Million
Q2 2024 Aug 15, 2024	SELL	$129.52 - $174.32 $2.33 Million - $3.14 Million	-18,000 Reduced 27.82%	46,700 $6.66 Million
Q1 2024 May 07, 2024	BUY	$141.8 - $181.47 $4.54 Million - $5.81 Million	32,000 Added 97.86%	64,700 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $95,201 - $120,948	-600 Reduced 1.8%	32,700 $5.9 Million
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $2.52 Million - $3.15 Million	14,000 Added 72.54%	33,300 $5.99 Million
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $4.6 Million - $6.88 Million	-25,800 Reduced 57.21%	19,300 $3.44 Million
Q1 2023 May 16, 2023	BUY	$215.53 - $274.5 $6.27 Million - $7.99 Million	29,100 Added 181.88%	45,100 $9.72 Million
Q4 2022 Feb 14, 2023	BUY	$125.51 - $229.3 $1.29 Million - $2.36 Million	10,300 Added 180.7%	16,000 $3.52 Million
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $421,760 - $647,168	-3,200 Reduced 35.96%	5,700 $768,000
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $121,110 - $216,050	-1,000 Reduced 10.1%	8,900 $1.44 Million
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $3.5 Million - $6.44 Million	-23,900 Reduced 70.71%	9,900 $1.87 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $3.63 Million - $5.68 Million	14,600 Added 76.04%	33,800 $9.16 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $4.37 Million - $7.05 Million	17,500 Added 1029.41%	19,200 $6.97 Million
Q2 2021 Aug 11, 2021	SELL	$292.75 - $367.01 $1.02 Million - $1.28 Million	-3,500 Reduced 67.31%	1,700 $583,000
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $417,024 - $611,392	-1,600 Reduced 23.53%	5,200 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $4.23 Million - $6.05 Million	-19,100 Reduced 73.75%	6,800 $1.76 Million
Q3 2020 Nov 16, 2020	BUY	$189.18 - $286.44 $1.61 Million - $2.43 Million	8,500 Added 48.85%	25,900 $7.42 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $2.48 Million - $3.91 Million	-20,000 Reduced 53.48%	17,400 $3.28 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $2.19 Million - $3.12 Million	18,000 Added 92.78%	37,400 $4.6 Million
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $1.6 Million - $2.88 Million	-13,800 Reduced 41.57%	19,400 $3.22 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $2.09 Million - $2.57 Million	17,300 Added 108.81%	33,200 $4.07 Million
Q2 2019 Aug 14, 2019	SELL	$113.99 - $146.86 $3.28 Million - $4.23 Million	-28,800 Reduced 64.43%	15,900 $1.97 Million
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $2.75 Million - $3.4 Million	22,400 Added 100.45%	44,700 $5.9 Million
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $2.35 Million - $3.85 Million	-22,000 Reduced 49.66%	22,300 $3.13 Million
Q3 2018 Nov 14, 2018	SELL	$152.62 - $189.66 $641,004 - $796,572	-4,200 Reduced 8.66%	44,300 $7.63 Million
Q2 2018 Aug 14, 2018	SELL	$152.5 - $216.77 $13.1 Million - $18.6 Million	-85,900 Reduced 63.91%	48,500 $7.46 Million
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $9.66 Million - $17.6 Million	99,200 Added 281.82%	134,400 $22.6 Million
Q4 2017 Feb 14, 2018	SELL	$79.6 - $114.73 $127,359 - $183,568	-1,600 Reduced 4.35%	35,200 $3.44 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $2.44 Million - $3.81 Million	36,800	36,800 $3.81 Million

Others Institutions Holding BGNE

# of Institutions

249

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.22 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$980 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$941 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$701 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account